DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
S•••••• I••••••••• H•••••••• L••
Pharmaceuticalsgroup grade Bon a schedule nowsponsor unattributed
Principal held
at least $10.4M
sum of BDC pieces, a lower bound
Fair value
$9.8M
95c on cost, debt pieces
Unfunded
$977,000
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Sep 17, 2030
no dated debt inside 24 months
On the tape since
Sep 30, 2024
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $10.2M | 96c | SOFR+525 bp | Sep 17, 2030 | 1 |
| first lien revolver first lien | at least $172,000 | 71c | SOFR+525 bp | Sep 17, 2030 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| F•••• E•••• P•••••• C••••• F••• | term loan first lien F•••• L••• D••• R•••••••• R••• and S••••• S + 5.25% I••••••• R••• F•••• 1.00% I••••••• R•• | $10.2M | $9.7M 96c | SOFR+525 bp |
| F•••• E•••• P•••••• C••••• F••• | revolver first lien C••••••••• T••• R••••••• C••••••••• E••••••••• D••• 9/17/2030 | n/a | n/a | |
| F•••• E•••• P•••••• C••••• F••• | revolver first lien F•••• L••• D••• R•••••••) R••••• United S••••• R•••••••• R••• and S••••• S + 5.25% I•••••• | $172,000 | $115,000 71c | SOFR+525 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $10.4M | $9.8M | 95c | 0 |
| Mar 31, 2026 | 1 | $10.4M | $9.6M | 93c | 0 |
| Dec 31, 2025 | 1 | $10.3M | $9.4M | 92c | 0 |
| Sep 30, 2025 | 1 | $10.3M | $9.5M | 93c | 0 |
| Jun 30, 2025 | 1 | $10.3M | $9.6M | 94c | 0 |
| Mar 31, 2025 | 1 | $10.4M | $9.9M | 97c | 0 |
| Dec 31, 2024 | 1 | $20.8M | $20.5M | 100c | 0 |
| Sep 30, 2024 | 1 | $10.4M | $10.3M | 100c | 0 |
What changed
- Mark recoveredJun 30, 2026
- New borrower on a BDC scheduleSep 30, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- SYNERderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it